Skip to content

Clinical trials

Phase 2 Neoplasm Metastasis trials in Croatia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Phase: Phase 2 Country / region: Croatia Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20081
20092
20101
20171
20181
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Unknown status3
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Acrotech Biopharma Inc.1
Croatian Cooperative Group for Clinical Research in Oncology1
G1 Therapeutics, Inc.1
Mirati Therapeutics Inc.1
Pfizer1
PharmaEngine1
Puma Biotechnology, Inc.1
South Eastern European Research Oncology Group1
University Hospital Sestre Milosrdnice1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis9
Breast Neoplasms4
Adenocarcinoma1
Carcinoma1
Carcinoma, Non-Small-Cell Lung1
Carcinoma, Transitional Cell1
Esophageal Neoplasms1
Lung Neoplasms1
Prostatic Neoplasms1
Recurrence1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.